{"id":"https://openalex.org/A5136946288","orcid":null,"observed_orcids":[],"display_name":"David O. Oyerinde","raw_author_names":["David O. Oyerinde"],"full_name":"David O. Oyerinde","works_count":2,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5136946288","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I43427933","ror":"https://ror.org/02q5h6807","display_name":"Federal University Oye Ekiti","country_code":"NG","type":"education","lineage":["https://openalex.org/I43427933"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I43427933","ror":"https://ror.org/02q5h6807","display_name":"Federal University Oye Ekiti","country_code":"NG","type":"education","lineage":["https://openalex.org/I43427933"]}],"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":2,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","count":2,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12257","display_name":"Bioactive natural compounds","count":1,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","value":1.51e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","value":1.49e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12257","display_name":"Bioactive natural compounds","value":8.8e-06,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","score":0.5292999744415283},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.47099998593330383},{"id":"59593255","wikidata":"https://www.wikidata.org/wiki/Q901663","display_name":"Molecular dynamics","score":0.42829999327659607},{"id":"2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","score":0.41679999232292175},{"id":"107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","score":0.2980000078678131}],"counts_by_year":[{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":1}],"display_name_alternatives":["David O. Oyerinde"],"block_key":"d oyerinde","works_api_url":"https://api.openalex.org/works?filter=author.id:A5136946288","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5136946288","updated_date":"2026-11-16T12:53:42","created_date":"2026-05-26T00:00:00"}
